Relationship of homocysteine with other risk factors and outcome of ischemic stroke

Clinical Neurology and Neurosurgery

Volumn 111, Issue 4, 2009, Pages 364-367

  Kalita, Jayantee ^a   Kumar, Gyanendra ^a   Bansal, Vikas ^a   Misra, Usha Kant ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CT; Homocysteine; Ischemic stroke; MRI; Outcome; Risk factors

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIET; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; RISK FACTOR; SITTING; SMOKING; VEGETARIAN;

ADULT; AGED; BRAIN ISCHEMIA; COMORBIDITY; DIABETES MELLITUS; DIET, VEGETARIAN; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; HYPERTENSION; INDIA; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; STROKE; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN B 12;

EID: 63449091824     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.12.010     Document Type: Article

References (34)

1. Hankey G.J., and Eikelboom J.W. Homocysteine and stroke. Curr Opin Neurol 14 (2001) 95-102
2. Hankey G.J., and Eikelboom J.W. Homocysteine and vascular disease. Lancet 354 (1999) 407-413
3. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., and Stampfer M.J. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25 (1994) 1924-1930
4. Kristensen B., Malm J., Nilsson T.K., Hultdin J., Carlberg B., Dahlen G., et al. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 30 (1999) 974-980
5. Linnebank M., Moskau S., Farmand S., Fliessbach K., Kolsch H., Bos M., et al. Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance. Stroke 37 (2006) 2840-2842
6. Tan N.C., Venketasubramanian N., Saw S.M., and Tjia H.T. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke 33 (2002) 1956-1962
7. Brattstrom L., Lindgren A., Israelsson B., Malinow M.R., Norrving B., Upson B., et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 22 (1992) 214-221
8. Verhoef P., Stampfer M.J., Buring J.E., Gaziano J.M., Allen R.H., Stabler S.P., et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B12, B6 and folate. Am J Epidemiol 143 (1996) 845-859
9. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 270 (1993) 2693-2698
10. Refsum H., Yajnik C.S., Gadkari M., Schneede J., Vollest S.E., Ornugl L., et al. Hyperhomocysteinemia and elevated methyl melonic acid indicate high prevalence of cobamin deficiency in Asian Indians. Am J Clin Nutr 74 (2001) 233-241
11. Perini F., Galloni E., Bogan I., Bader G., Ruffini R., Arzenton E., et al. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease. J Neurol Sci 26 (2005) 310-319
12. Mizrahi E.H., Fleissig Y., Arad M., and Adunsky A. Plasma homocysteine level and functional outcome of patients with ischemic stroke. Arch Phys Med Rehabil 86 (2005) 62-63
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-97.
14. Teasdale G., and Jennett B. Assessment of coma an impaired consciousness. A practical scale. Lancet ii (1974) 81-84
15. Cote R., Hachinski V.C., Shurrell B.L., Norris B.W., and Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 17 (1986) 731-737
16. Misra U.K., and Kalita J. Vitamin B12 deficiency neurological syndromes: correlation of clinical, MRI and cognitive evoked potential. J Neurol 255 (2008) 353-359
17. Healton E.B., Savege D.G., Brust J.C.M., Garrett T.J., and Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine 70 (1991) 229-245
18. Bostom A., and Lathrop L. Hyperhomocysteinemia in end stage renal disease: prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int 52 (1997) 10-20
19. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 15 (1998) 1042-1050
20. Mizrahi E.H., Fleissig Y., Arad M., and Adunsky A. Plasma homocysteine level and functional outcome of patients with ischaemic stroke. Arch Phys Med Rehabil 86 (2005) 60-63
21. Anand S.S., Yusuf S., Vuksan V., Devanesen S., Teo K.K., Montague P.A., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356 (2000) 279-284
22. Misra A., Vikram N.K., Pandey R.M., Dwivedi M., Ahmad F.U., Luthra K., et al. Hyperhomocysteinemia, and low intakes of folic acid and vitamin B12 in urban North India. Eur J Nutr 41 (2002) 68-77
23. Misra U.K., and Kalita J. Comparison of clinical and electrodiagnostic features in B12 deficiency neurological syndromes with and without antiparietal cell antibody. Postgrad Med J 83 (2007) 124-127
24. Kalita J., Srivastava R., Bansal V., Agarwal S., and Misra U.K. Methylenetetrahydrofolate reductase gene polymorphism in Indian stroke patients. Neurol India 54 (2006) 260-263
25. Alluri R.V., Mohan V., Komandur S., Chawda K., Chaudhuri J.R., and Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12 (2005) 40-44
26. Panigrahi I., Chatterjee T., Biswas A., Behari M., Choudhry P.V., and Saxena R. Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 54 (2006) 48-50
27. Dharmarajan T.S., Adiga G.U., and Norkus E.P. Vitamin B12 deficiency. Recognizing subtle symptoms in older adults. Geriatrics 58 (2003) 30-34
28. Khan U., Crossley C., Kalra L., Rudd A., Wolfe C.D.A., Collinson P., et al. Homocysteine and its relationship to stroke subtypes in a UK Black population the South London ethnicity and stroke study. Stroke 39 (2008) 2943-2949
29. Howard V.J., Sides E.G., Newman G.C., Cohen S.N., Howard G., Malinow M.R., et al. Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 33 (2000) 473-478
30. Dudman N.P.B. An alternative view of homocysteine. Lancet 354 (1999) 2072-2074
31. Lindgren A., Brattstrom L., Norrving B., Hultberg B., Andersson A., and Johansson B.B. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26 (1995) 795-800
32. Toole J.F., Malinow M.R., Chambless L.E., Spence J.D., Pettigrew L.C., Howard V.J., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 291 (2004) 565-575
33. Yoldas T., Gonen M., Godekmerdan A., Ilhan F., and Bayram E. The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischaemic stroke. Mediators Inflamm 2007 (2007) 15929
34. Okubadejo N.U., Oladipo O.O., Adeyomoye A.A., Awosanya G.O., and Danesi M.A. Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC Neurol 8 (2008) 26